Cargando…
Is subcutaneous insulin administration adequate for the management of hyperglycemic crisis in COVID-19?
There is a desperate need to explore different insulin administration strategies, particularly in coronavirus disease 2019 (COVID-19) patients with hyperglycemic crisis. Noteworthily, diabetes mellitus (DM) and poorly controlled blood glucose increase the risk of mortality and severity of COVID-19....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd on behalf of Diabetes India.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301814/ https://www.ncbi.nlm.nih.gov/pubmed/32599534 http://dx.doi.org/10.1016/j.dsx.2020.06.032 |